Literature DB >> 13520143

Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis.

C D WEST.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; NEPHROTIC SYNDROME/in infant and child; NITROGEN MUSTARDS/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13520143     DOI： 10.1001/archpedi.1958.02060050502007

Source DB:  PubMed          Journal:  AMA J Dis Child        ISSN： 0096-6916


× No keyword cloud information.
  5 in total

1.  Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

Authors:  K N Drummond; D A Hillman; J H Marchessault; W Feldman
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

2.  Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors:  R H White; J S Cameron; J R Trounce
Journal:  Br Med J       Date:  1966-10-08

Review 3.  The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.

Authors:  J Brodehl
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

Review 4.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 5.  History of Nephrotic Syndrome and Evolution of its Treatment.

Authors:  Abhijeet Pal; Frederick Kaskel
Journal:  Front Pediatr       Date:  2016-05-30       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.